Microalbuminuria is well established as a marker for early renal damage in diabetic patients. Differences in charge selectivity in glomerular protein filtration may also be an early marker of renal damage. We investigated the possible usefulness of the renal clearances of pancreatic and salivary amylases, and the ratio of the two, as markers of early renal damage in 55 diabetic subjects and 21 healthy controls. Diabetic patients with established albuminuria and microalbuminuria had increased clearance of salivary amylase and a trend toward lower pancreatic/salivary amylase clearance ratios compared to healthy controls and diabetic subjects without albuminuria, but the overlap with controls and diabetics without albuminuria was too large for the test to be useful.
MogensenCEMicroalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med1984; 310: 356–60
2.
JarrettRJVibertiGCArgyorpoulosAHillRGMahmudUMurrellsTJMicroalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabetic Med1984; 1: 17–20
3.
YudkinJSForrestRDJacksonCAMicroalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet1988; ii: 530–3
4.
DamsgaardEMFrolandAJorgensenODMogensenCEMicroalbuminuria as predictor of increased mortality in elderly people. BMJ1990; 300: 297–300
5.
PurtellJNPesceAJClyneDHMillerWCPollackVEIsoelectric point of albumin: effect on renal handling of albumin. Kidney Int1979; 16: 366–76
6.
RennkeHGVenkatachalamMAGlomerular permeability. In vivo tracer studies with polyanionic and polycationic ferritins. Kidney Int1977; 11: 44–53
7.
WetzelsJFMHafkenschiedJCMHesselsMHoitsmaAJKoeneRAPRenal clearance of pancreatic and salivary amylase relative to creatinine clearance in patients with renal disease and proteinuria. Clin Chem1988; 34: 589–91
8.
WoolertonJJuryDRDunnPJSpeedJFUrine albumin creatinine ratio and clinical correlates in a diabetic population. NZ Med J1987; 100: 130–4
9.
RauscherEBulowSVHagleEONeumannUSchaichEA modified substrate for the determination of a-amylase. Fresenius Z Anal Chem1986; 324: 304–5
10.
TietzNWBurlinaAGerhardtWJungeWMalfertheinerPMuraiTMulticenter evaluation of specific pancreatic isoamylase assay based on a double monoclonal-antibody technique. Clin Chem1988; 34: 2096–102
11.
SpencerKAnalytical reviews in clinical biochemistry: the estimation of creatinine. Ann Clin Biochem1986; 23: 1–25
12.
SpencerKPriceCPKinetic immunoturbidimetry: the estimation of albumin. Clin Chim Acta1979; 95: 263–76
13.
WatanabeNKameiSOhkuboAYamanakaMOhsawaSMakinoKUrinary protein as measured with a pyrogallol red-molybdate complex, manually and in a Hitachi 726 automated analyser. Clin Chem1986; 32: 1551–4
14.
FoxJGO'ReillyDSTotal amylase and pancreatic isoamylase in serum and urine (Letter). Ann Clin Biochem1990; 27: 94–5
15.
KaysenGAProteinuria as a marker of glomerular injury. In: NothRH, ed. Diabetic nephropathy: Hemodynamic basis and implications for disease management. Ann Intern Med1989; 110: 795–813
16.
BernardAMOuledAmor AAGoemaere-VannesteJAntoineJLLauwerysRRLambertAMicro-transferrinuria is a more sensitive indicator of early glomerular damage in diabetes than microalbuminuria. Clin Chem1988; 34: 1920–1
17.
CheungCKCockramCSYeungVTFSwaminathanRUrinary excretion of transferrin by non-insulin-dependent diabetics: a marker for early complications?Clin Chem1989; 35: 1672–4
18.
DeenWMBridgesCRBrennerBMBiophysical basis of glomerular permselectivity. J Membr Biol1983; 71: 1–10
19.
NakamuraYMyersBDChange selectivity of proteinuria in diabetic glomerulopathy. Diabetes1988; 37: 1202–11
20.
ParthasarathyNSpiroRGEffect of diabetes on the glycosaminoglycan component of the human glomerular basement membrane. Diabetes1982; 31: 738–41
21.
GhiggeriGMCandianoGDelfinoGQueiroloCElectrical charge of serum and urinary albumin in normal and diabetic humans. Kidney Int1985; 28: 168–77
